Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LH1753

Catalog No. T88169Cas No. 2650492-10-5

LH1753 is an orally active inhibitor of L-cystine crystallization, with an EC50 of 29.5 nM. It is applicable in research related to Cystinuria.

LH1753

LH1753

Catalog No. T88169Cas No. 2650492-10-5
LH1753 is an orally active inhibitor of L-cystine crystallization, with an EC50 of 29.5 nM. It is applicable in research related to Cystinuria.
Pack SizePriceAvailabilityQuantity
10 mgInquiry10-14 weeks
50 mgInquiry10-14 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
LH1753 is an orally active inhibitor of L-cystine crystallization, with an EC50 of 29.5 nM. It is applicable in research related to Cystinuria.
In vivo
LH1753 (150 μmol/kg, administered orally, once daily for eight weeks) inhibits the formation of L-cystine stones but does not affect the growth of the cystinuria mouse model with Slc3a1 gene knockout [1].
Chemical Properties
Molecular Weight630.57
FormulaC22H44Cl4N6O2S2
Cas No.2650492-10-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy LH1753 | purchase LH1753 | LH1753 cost | order LH1753 | LH1753 chemical structure | LH1753 in vivo | LH1753 formula | LH1753 molecular weight